Microbiota and Aging. A Review and Commentary

Archives of Medical Research

Volumn 48, Issue 8, 2017, Pages 681-689

  García Peña, Carmen ^a   Álvarez Cisneros, Teresa ^a   Quiroz Baez, Ricardo ^a   Friedland, Robert P ^b  

^a INSTITUTO NACIONAL DE GERIATRÍA   (Mexico)

^b University of Louisville School of Medicine   (United States)

Author keywords

Aging; Frailty; Inmunoinflamatory system; Microbiota; Neurodegeneration

Indexed keywords

AGING; ALZHEIMER DISEASE; FRAILTY; GERIATRIC DISORDER; HEALTH; HUMAN; LONGEVITY; MENTAL DISEASE; MICROFLORA; MUCOSAL IMMUNITY; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; REVIEW; AGED; IMMUNE SYSTEM; INFLAMMATION; INTESTINE FLORA; MICROBIOLOGY; PHYSIOLOGY;

AGED; AGING; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM; INFLAMMATION;

EID: 85044774736     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2017.11.005     Document Type: Review

References (106)

1. Fierer, N., Hamady, M., Lauber, C.L., et al. The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc Natl Acad Sci USA 105 (2008), 17994–17999.
2. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., et al. A core gut microbiom in obese and lean twins. Nature 457 (2009), 480–484.
3. Neish, A.S., Microbes in gastrointestinal health and disease. Gastroenterology 136 (2009), 65–80.
4. Guigoz, Y., Doré J., Schiffrin, E.J., The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care 11 (2008), 13–20.
5. Woodmansey, E.J., Intestinal bacteria and ageing. J Appl Microbiol 102 (2007), 1178–1186.
6. Arumugam, M., Raes, J., Pelletier, E., et al. Enterotypes of the human gut microbiome. Nature 473 (2011), 174–180.
7. Wu, G.D., Chen, J., Hoffmann, C., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
8. Qin, J., Li, R., Raes, J., et al. A human gut microbial gene catalog established by metagenomic sequencing. Nature 464 (2010), 59–65.
9. Yatsunenko, T., Rey, F.E., Manary, M.J., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
10. Koenig, J.E., Spor, A., Scalfone, N., et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 108 (2011), 4578–4585.
11. Biagi, E., Candela, M., Franceschi, C., et al. The aging gut microbiota: New perspectives. Ageing Res Rev 10 (2011), 428–429.
12. Magrone, T., Jirillo, E., Moore, W., et al. The interaction between gut microbiota and age-related changes in immune function and inflammation. Immun Ageing, 10, 2013, 31.
13. Turnbaugh, P., Ley, R., Mahowald, M., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature2 444 (2006), 1027–1131.
14. Ghaisas, S., Maher, J., Kanthasamy, A., Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacol Ther 158 (2016), 52–62.
15. Leung, K., Thuret, S., Gut microbiota: a modulator of brain plasticity and cognitive function in ageing. Healthcare 3 (2015), 898–916.
16. Gosalbes, M.J., Llop, S., Vallès, Y., et al. Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants. Clin Exp Allergy 43 (2013), 198–211.
17. Biasucci, G., Benenati, B., Morelli, L., et al. Cesarean delivery may affect the early biodiversity of intestinal bacteria. J Nutr 138 (2008), 1796S–1800S.
18. Grölund, M.M., Lehtonen, O.P., Eerola, E., et al. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 28 (1999), 19–25.
19. Harmsen, H.J.M., Wildeboer–Veloo, A.C.M., Raangs, G.C., et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30 (2000), 61–67.
20. O'Sullivan, A., Farver, M., Smilowitz, J.T., The influence of early infant-feeding practices on the intestinal microbiome and body composition in infants. Nutr Metab Insights 8:Suppl 1 (2015), 1–9.
21. Jermy, A., Symbiosis: Host genes shape the gut microbiota. Nat Rev Microbiol 8 (2010), 838–839.
22. Palmer, C., Bik, E.M., DiGiulio, D.B., et al. Development of the human infant intestinal microbiota. PLoS Biology 5 (2007), 1556–1573.
23. Salazar, N., Arboleya, S., Valdés, L., et al. The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations. Front Genet 5 (2014), 1–9.
24. Lloyd-Price, J., Abu-Ali, G., Huttenhower, C., The healthy human microbiome. Genome Med, 8, 2016, 51.
25. Kong, F., Hua, Y., Zeng, B., et al. Gut microbiota signatures of longevity. Curr Biol 26 (2016), R832–R833.
26. Franceschi, C., Bonafè M., Valensin, S., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908 (2000), 244–254.
27. Claesson, M.J., Cusack, S., O'Sullivan, O., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 108:Suppl. 1 (2011), 4586–4591.
28. Odamaki, T., Kato, K., Sugahara, H., et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiology, 16, 2016, 90.
29. Hopkins, M.J., Sharp, R., Macfarlane, G.T., Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48 (2001), 198–205.
30. Mueller, S., Saunier, K., Hanisch, C., et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72 (2006), 1027–1033.
31. Mariat, D., Firmesse, O., Levenez, F., et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiology, 9, 2009, 123.
32. Zwielehner, J., Liszt, K., Handschur, M., et al. Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol 44 (2009), 440–446.
33. Biagi, E., Nylund, L., Candela, M., et al. Through ageing, and beyond: Gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE, 2010, 5.
34. Claesson, M.J., Jeffery, I.B., Conde, S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488 (2012), 178–184.
35. Andersson, A.F., Lindberg, M., Jakobsson, H., et al. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS ONE, 3, 2008, e2836.
36. Tap, J., Mondot, S., Levenez, F., et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 11 (2009), 2574–2584.
37. Round, J.L., Mazmanian, S.K., The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9 (2009), 313–324.
38. Collino, S., Montoliu, I., Martin, F.P.J., et al. Metabolic signatures of extreme longevity in Northern Italian centenarians reveal a complex remodeling of Lipids, Amino Acids, and Gut Microbiota Metabolism. PLoS ONE, 2013, 8.
39. Xu, X.M., Sansores-Garcia, L., Chen, X.M., et al. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc Natl Acad Sci USA 96 (1999), 5292–5297.
40. Mabbott, N.A., Kobayashi, A., Sehgal, A., et al. Aging and the mucosal immune system in the intestine. Biogerontology 16 (2015), 133–145.
41. Tomasello, E., Bedoui, S., Intestinal innate immune cells in gut homeostasis and immunosurveillance. Immunol Cell Biol 91 (2013), 201–203.
42. Fujihashi, K., McGhee, J.R., Mucosal immunity and tolerance in the elderly. Mech Ageing Dev 125 (2004), 889–898.
43. Schmucker, D.L., Owen, R.L., Outenreath, R., et al. Basis for the age-related decline in intestinal mucosal immunity. Clin Dev Immunol 10:2–4 (2003), 167–172.
44. Smith, P.D., Smythies, L.E., Shen, R., et al. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol 4 (2011), 31–42.
45. Campisi, J., d'Adda di Fagagna, F., Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8 (2007), 729–740.
46. Firth, M., Prather, C.M., Gastrointestinal motility problems in the elderly patient. Gastroenterology 122 (2002), 1688–1700.
47. Mabbott, N.A., A breakdown in communication? Understanding the effects of aging on the human small intestine epithelium. Clin Sci 129 (2015), 529–531.
48. Clements, S.J., Carding, S.R., Diet, the intestinal microbiota and immune health in ageing. Crit Rev Food Sci Nutr, 2016, 1–11.
49. Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., et al. Effect of probiotic supplementation on cognitive function and metabolic status in alzheimer's disease: a randomized, double-blind and controlled trial. Front Aging Neurosci, 8, 2016, 256.
50. Isolauri, E., Kirjavainen, P.V., Salminen, S., Probiotics: a role in the treatment of intestinal infection and inflammation?. Gut 50:Suppl 3 (2002), III54–III59.
51. Isolauri, E., Sütas, Y., Kankaanpää P., et al. Probiotics: effects on immunity. Am J Clin Nutr 73:2 Suppl (2001), 444S–450S.
52. Guarner, F., Malagelada, J.R., Gut flora in health and disease. Lancet 361 (2003), 512–519.
53. Gill, H., Prasad, J., Probiotics, Immunomodulation, and Health Benefits. Bioactive Components of Milk, 2008, Springer New York, New York, NY, 423–454.
54. Hakansson, A., Molin, G., Gut microbiota and inflammation. Nutrients 3 (2011), 637–682.
55. Isolauri, E., Salminen, S., Ouwehand, A.C., Probiotics. Best Pract Res Clin Gastroenterol 18 (2004), 299–313.
56. Hayashi, H., Sakamoto, M., Benno, Y., Fecal microbial diversity in a strict vegetarian as determined by molecular analysis and cultivation. Microbiol Immunol 46 (2002), 819–831.
57. Zhang, C., Li, S., Yang, L., et al. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun, 4, 2013, 2163.
58. Zhu, Y., Li, H., Xu, X., et al. The gut microbiota in young and middle-aged rats showed different responses to chicken protein in their diet. BMC Microbiology, 16, 2016, 281.
59. Paddon-Jones, D., Campbell, W.W., Jacques, P.F., et al. Protein and healthy aging. Am J Clin Nutr 101 (2015), 1339S–1345S.
60. Benno, Y., Endo, K., Mizutani, T., et al. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol 55 (1989), 1100–1105.
61. Weldon, L., Abolins, S., Lenzi, L., et al. The gut microbiota of wild mice. PLoS ONE 10 (2015), 1–15.
62. Costello, E.E.K., Lauber, C.C.L., Hamady, M., et al. Bacterial community variation in human body habitats across space and time. Science 326 (2009), 1694–1697.
63. Grice, E.A., Kong, H.H., Conlan, S., et al. Topographical and temporal diversity of the human skin microbiome. Science 324 (2009), 1190–1192.
64. Aziz, Q., Thompson, D.G., Brain-gut axis in health and disease. Gastroenterology 114 (1998), 559–578.
65. Collins, S.M., Surette, M., Bercik, P., The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10 (2012), 735–742.
66. Grenham, S., Clarke, G., Cryan, J.F., et al. Brain-gut-microbe communication in health and disease. Front Physiol 2 (2011), 1–15.
67. Koh, A., De Vadder, F., Kovatcheva-Datchary, P., et al. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 165 (2016), 1332–1345.
68. Lyte, M., Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathogens, 2013, 9.
69. Wall, R., Cryan, J.F., Paul Ross, R., et al. Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol 817 (2014), 221–239.
70. O'Mahony, S.M., Clarke, G., Borre, Y.E., et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research 277 (2015), 32–48.
71. Scott, L.V., Clarke, G., Dinan, T.G., The brain-gut axis: A target for treating stress-related disorders. Mod Trends Pharmacopsychiatry 28 (2013), 90–99.
72. Wang, Y., Kasper, L.H., The role of microbiome in central nervous system disorders. Brain Behav 38 (2014), 1–12.
73. O'Mahony, S.M., Marchesi, J.R., Scully, P., et al. Early life stress alters behavior, immunity, and microbiota in rats: Implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 65 (2009), 263–267.
74. Dinan, T.G., Quigley, E.M.M., Ahmed, S.M.M., et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker?. Gastroenterology 130 (2006), 304–311.
75. Sampson, T.R., Mazmanian, S.K., Control of brain development, function, and behavior by the microbiome. Cell Host and Microbe 17 (2015), 565–576.
76. Heijtz, R.D., Wang, S., Anuar, F., et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci 108 (2011), 3047–3052.
77. Neufeld, K.M., Kang, N., Bienenstock, J., et al. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil, 2011, 23.
78. Miraglia, F., Betti, L., Palego, L., et al. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge. Cent Nerv Syst Agents Med Chem 15 (2015), 109–116.
79. Svensson, E., Horváth-Puhó E., Thomsen, R.W., et al. Vagotomy and subsequent risk of Parkinson's disease. Ann Neurol 78 (2015), 522–529.
80. Scheperjans, F., Aho, V., Pereira, P.A.B., et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 30 (2015), 350–358.
81. Keshavarzian, A., Green, S.J., Engen, P.A., et al. Colonic bacterial composition in Parkinson's disease. Mov Disord 30 (2015), 1351–1360.
82. Felice, V.D., Quigley, E.M., Sullivan, A.M., et al. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. Parkinsonism Relat Disord 27 (2016), 1–8.
83. Selkoe, D.J., Alzheimer's Disease: Genes, Proteins, and Therapy. Physiol Rev 81 (2001), 741–766.
84. Hardy, J., Has the amyloid cascade hypothesis for Alzheimer's disease been proved?. Curr Alzheimer Res 3 (2006), 71–73.
85. Cattaneo, A., Cattane, N., Galluzzi, S., et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 49 (2017), 60–68.
86. Lukiw, W.J., Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer's disease. Front Microbiol, 7, 2016, 1544.
87. Distrutti, E., O'Reilly, J.A., McDonald, C., et al. Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. PLoS ONE, 2014, 9.
88. Friedland, R.P., Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. J Alzheimers Dis 45 (2015), 349–362.
89. Minter, M.R., Taylor, J.M., Crack, P.J., The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease. J Neurochem 136 (2016), 457–474.
90. Chen, L.K., Chen, Y.M., Lin, M.H., et al. Care of elderly patients with diabetes mellitus: a focus on frailty. Ageing Res Rev 9:Suppl 1 (2010), S18–S22.
91. Sampson, T.R., Debelius, J.W., Thron, T., et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of parkinson's disease. Cell 167 (2016), 1469–1480.
92. Franceschi, C., Campisi, J., Chronic Inflammation (Inflammaging) and its potential contribution to Age-associated diseases. Journals Gerontol Ser A Biol Sci Med Sci 69:Suppl 1 (2014), S4–S9.
93. Xue, Q.-L., The frailty syndrome: definition and natural history. Clin Geriatr Med 27 (2011), 1–15.
94. van Tongeren, S.P., Slaets, J.P.J., Harmsen, H.J.M., et al. Fecal microbiota composition and frailty. Appl Environ Microbiol 71 (2005), 6438–6442.
95. Jackson, M.A., Jeffery, I.B., Beaumont, M., et al. Signatures of early frailty in the gut microbiota. Genome Med, 8, 2016, 8.
96. Langille, M.G., Meehan, C.J., Koenig, J.E., et al. Microbial shifts in the aging mouse gut. Microbiome, 2, 2014, 50.
97. Tang, W., Bhatt, A., Smith, A.N., et al. Specific binding of a naturally occurring amyloidogenic fragment of Streptococcus mutans adhesin P1 to intact P1 on the cell surface characterized by solid state NMR spectroscopy. J Biomol NMR 64 (2016), 153–164.
98. Watanabe, I., Kuriyama, N., Miyatani, F., et al. Oral Cnm-positive streptococcus mutans expressing collagen binding activity is a risk factor for cerebral microbleeds and cognitive impairment. Sci Rep 6 (2016), 1–10.
99. O'Keefe, S.J.D., Li, J.V., Lahti, L., et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun, 6, 2015, 6342.
100. Pérez Martínez, G., Bäuerl, C., Collado, M., Understanding gut microbiota in elderly's health will enable intervention through probiotics. Benef Microbes 5 (2014), 235–246.
101. Lowry, C., Smith, D., Siebler, P., et al. The microbiota, immunoregulation, and mental health: implications for public health. Curr Environ Health Rep 3 (2016), 270–286.
102. Zhang, X., Zheng, X., Yuan, Y., Treatment of insulin resistance: straight from the gut. Drug Discov Today 21 (2016), 1284–1290.
103. Nehra, V., Allen, J., Mailing, L., et al. Gut microbiota: modulation of host physiology in obesity. Physiology 31 (2016), 327–335.
104. Marin, I., Goertz, J., Ren, T., et al. Microbiota alteration is associated with the development of stress induced despair behavior. Sci Rep, 2016, 7.
105. Chen, Z., Guo, L., Zhang, Y., et al. Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. J Clin Invest 124 (2014), 3391–3406.
106. Steidler, L., Genetically engineered probiotics. Best Pract Res Clin Gastroenterol 17 (2003), 861–876.